Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Uric acid is important, but there is something that matters even more: to deliver sacubitril/valsartan to eligible heart failure patients.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): Costanzo MR;Costanzo MR
  • Source:
    European journal of heart failure [Eur J Heart Fail] 2018 Mar; Vol. 20 (3), pp. 523-524. Date of Electronic Publication: 2018 Jan 12.
  • Publication Type:
    Editorial; Comment
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE
    • Publication Information:
      Publication: 2014- : Chichester : Wiley
      Original Publication: Amsterdam ; New York : Elsevier Science, c1999-
    • Subject Terms:
      Heart Failure* ; Uric Acid*; Aminobutyrates ; Angiotensin Receptor Antagonists ; Biphenyl Compounds ; Drug Combinations ; Humans ; Tetrazoles ; Valsartan
    • Comments:
      Comment on: Eur J Heart Fail. 2018 Mar;20(3):514-522. doi: 10.1002/ejhf.1056. (PMID: 29193563)
    • Accession Number:
      0 (Aminobutyrates)
      0 (Angiotensin Receptor Antagonists)
      0 (Biphenyl Compounds)
      0 (Drug Combinations)
      0 (Tetrazoles)
      268B43MJ25 (Uric Acid)
      80M03YXJ7I (Valsartan)
      WB8FT61183 (sacubitril and valsartan sodium hydrate drug combination)
    • Publication Date:
      Date Created: 20180113 Date Completed: 20181023 Latest Revision: 20211204
    • Publication Date:
      20250114
    • Accession Number:
      10.1002/ejhf.1087
    • Accession Number:
      29327807